海马结构
神经科学
磷酸化
淀粉样前体蛋白
化学
τ蛋白
阿尔茨海默病
P3肽
阿尔茨海默病的生物化学
生物化学
生物
疾病
内科学
医学
作者
Bowen Zheng,Li Yang,Xueling Dai,Zhao-Feng Jiang,Han‐Chang Huang
标识
DOI:10.1080/01616412.2015.1133485
摘要
Alzheimer disease (AD), a central nervous system degenerative disease, is characterized by abnormal deposition of amyloid-β peptide (Aβ), neurofibrillary tangles formed by hyperphosphorylated tau and synaptic loss. It is widely accepted that Aβ is the chief culprit of AD. Aβ peptide is the cleavage product of amyloid-β precursor protein (APP). Recently, more attention has been paid to O-linked β-N-acetylglucosaminylation (O-GlcNAcylation) modification of protein. O-GlcNAcylation plays a significant role in hippocampal synaptic function. Abated O-GlcNAcylation might be a modulator in progression of AD through regulating activity of pertinent enzymes and factors. Evidence suggests that enhanced O-GlcNAcylation interacts with tau phosphorylation and prevents brain from tau and Aβ-induced impairment. Here, we review the roles of O-GlcNAcylation in APP cleavage, tau phosphorylation and hippocampal synapses function.
科研通智能强力驱动
Strongly Powered by AbleSci AI